Inhibition of β-Catenin Translocation in Rodent Colorectal Tumors: A Novel Explanation for the Protective Effect of Nonsteroidal Antiinflammatory Drugs in Colorectal Cancer
- 1 January 2001
- journal article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 46 (11) , 2314-2321
- https://doi.org/10.1023/a:1012326525692
Abstract
In a rodent colorectal cancer model, nonsteroidal antiinflammatory drugs reduce tumor mass by increasing the rate of tumor cell apoptosis and decreasing proliferation. We have examined β-catenin as a...Keywords
This publication has 45 references indexed in Scilit:
- Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradictionMedical Hypotheses, 2000
- Synergy Between Tumor Suppressor APC and the β-Catenin-Tcf4 Target Tcf1Science, 1999
- The cyclin D1 gene is a target of the β-catenin/LEF-1 pathwayProceedings of the National Academy of Sciences, 1999
- The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumorsOncogene, 1999
- Identification of c- MYC as a Target of the APC PathwayScience, 1998
- Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis.1997
- CYCLOOXYGENASE-2 INHIBITORS: A New Class of Anti-Inflammatory Agents That Spare the Gastrointestinal TractGastroenterology Clinics of North America, 1996
- Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumorsGastroenterology, 1996
- Aspirin and the Risk of Colorectal Cancer in WomenNew England Journal of Medicine, 1995
- Expression of cyclooxygenase-1 and -2 in human colorectal cancer.1995